by Steven Grossman | Nov 11, 2025 | Short Takes and Updates
Over the past two weeks, several news stories have reported low morale at FDA. Although they all reached the same conclusion, each story focused on a different driver. One was about how the shutdown was exacerbating low morale; another focused on the cumulative impact...
by Steven Grossman | Oct 31, 2025 | Short Takes and Updates
To keep our country safe, counterterrorism efforts must be operational and effective 24/7/365. It only takes one terrorist at one specific moment to create a catastrophe.When it comes to food and medical products, FDA is our nation’s Department of Homeland Security....
by Steven Grossman | Oct 24, 2025 | Short Takes and Updates
Since the founding of our republic, there has been debate about states’ rights vs federal rights. And in times of stress, the discussion gets more heated and gains more traction. Once again, FDA is moving into the center of such debates. Federalism is at the Heart of...
by Steven Grossman | Oct 14, 2025 | Short Takes and Updates
The announcement that former CBER Director, Dr. Peter Marks, was joining Lilly as SVP for molecule discovery and head of infectious diseases….set the internet ablaze with unjustified outrage about his transition from a government career to industry. My multiple...
by Steven Grossman | Oct 10, 2025 | Short Takes and Updates
Every day, our country is failing patients with relentlessly progressive chronic neurological, neuromuscular, and genetic diseases. Their plight necessitates a significantly different risk-benefit calculation than that of patients with other types of diseases....
by Steven Grossman | Oct 3, 2025 | Short Takes and Updates
Every Monday, FDA Mtters subscribers receive “Q&A Monday.” They may recirculate, quote from, or reprint it, etc., at their own discretion, which can be particularly useful for media. I do not publicly post the column until the following Monday. You can find past...
